IL17A and Alzheimer disease: The five pathways (PI3K-Akt, IL-17, JAK-STAT, TNF, and Ras signaling) identified from gene enrichment analysis of the DEGs represent potential changes in biochemical signaling over different stages of MCI and AD onset and development.